Skip to Content

Join the 'Meningitis - Meningococcal' group to help and get support from people like you.

Meningitis - Meningococcal News

Another Neurological Disorder Tied to Zika

Posted 10 Mar 2016 by

WEDNESDAY, March 9, 2016 – The list of neurological disorders potentially associated with the Zika virus continues to grow, health officials reported Wednesday. Writing in the March 9 online edition of the New England Journal of Medicine, French researchers described the case of an unidentified 81-year-old man who had been in fine health before becoming feverish and then comatose while on a ...

New Bacterial Meningitis Vaccine Approved

Posted 26 Jan 2015 by

MONDAY, Jan. 26, 2015 – The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent the "serogroup B" form of bacterial meningitis among people aged 10 through 25. Meningococcal disease, or meningitis, is a life-threatening bacterial infection of the bloodstream and the lining that surrounds the brain and spinal cord. N. meningitis bacteria are commonly transmitted ...

FDA Approves Bexsero Vaccine to Prevent Serogroup B Meningococcal Disease

Posted 23 Jan 2015 by

January 23, 2015 – The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Bexsero is the second vaccine approved by the FDA in the past three months to prevent this disease. The agency approved the first meningococcal serogroup B vaccine in October ...

FDA Approves New Vaccine to Protect Against Meningitis

Posted 30 Oct 2014 by

WEDNESDAY, Oct. 29, 2014 – A new vaccine that could help prevent some cases of life-threatening meningococcal disease was approved by the U.S. Food and Drug Administration on Wednesday. Trumenba is approved to protect people between the ages of 10 and 25 from invasive meningococcal disease caused by Neisseria meningitidis serogroup B bacteria. The bacteria can infect the bloodstream (sepsis) and ...

FDA Approves Trumenba - First Vaccine to Prevent Serogroup B Meningococcal Disease

Posted 29 Oct 2014 by

October 29, 2014 – The U.S. Food and Drug Administration announced today the approval of Trumenba (meningococcal group B vaccine), the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Meningococcal disease is a life-threatening illness caused by bacteria that infect the ...

Vaccinations Belong on Parents' Back-to-School Checklists

Posted 20 Aug 2012 by

MONDAY, Aug. 20 – Vaccinations among school-aged children can save lives and parents should be sure their children are fully immunized as part of their back-to-school preparations, according to a pediatric infectious disease specialist. "These vaccines save children's lives; parents interested in keeping their child alive should have them vaccinated," Dr. David Kimberlin, a University of Alabama ...

Shots Should Be on College Kids' Back-to-School List

Posted 31 Jul 2012 by

TUESDAY, July 31 – Immunizations aren't just for young children – college students need them, too. That's the message an expert has for parents who will be seeing children off to college this month. "Children who are preparing for their freshman year in a dormitory are at increased risk for bacterial meningitis," Dr. Peter Wenger, associate professor at the University of Medicine and Dentistry ...

GSK Receives FDA Approval for MenHibrix

Posted 15 Jun 2012 by

PHILADELPHIA, June 14, 2012 /PRNewswire/ – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine]. MenHibrix is a vaccine indicated to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. ...

Study: More Pre-Teens Get Vaccines When Middle Schools Require Them

Posted 7 May 2012 by

MONDAY, May 7 – Pre-teens living in states that require vaccinations for incoming middle school students are more likely to be immunized than those in states without such requirements, a new study finds. Current vaccine guidelines from the U.S. Centers for Disease Control and Prevention recommend that boys and girls aged 11 to 12 receive three immunizations or boosters: ...

Vaccine Against Bacterial Meningitis Shows Promise

Posted 18 Jan 2012 by

WEDNESDAY, Jan. 18 – A new vaccine to protect against meningococcus B, a common cause of bacterial meningitis, shows promise in clinical trials, researchers in Chile report. Vaccines that protect from four other strains of Neisseria meningitides, a bacteria that causes meningococcal disease, are already in use or in the last stages of development, according to a news release from The Lancet. The ...

Doctors in a Bind When Parents Want to Delay, Skip Vaccines

Posted 28 Nov 2011 by

MONDAY, Nov. 28 – Mistrust of childhood vaccines is causing some parents to request "alternative" schedules from doctors, either delaying or skipping some shots. And a new study suggests that most pediatricians are willing to go along with these requests – up to a point. "Parents seem to be regularly requesting alternative childhood immunization schedules," noted co-author Dr. Douglas John ...

Vaccinations Aren't Just for Kids

Posted 16 Sep 2011 by

FRIDAY, Sept. 16 – Public health experts often focus immunization awareness efforts toward protecting children, and with good reason: Facing a potentially bewildering schedule of vaccinations for their young ones, parents usually need all the help they can get. But vaccinations aren't just kid stuff. Medical science is creating an increasing number of immunizations targeted at adults, to help ...

CDC Report Shows Bacterial Meningitis Cases on the Decline

Posted 25 May 2011 by

WEDNESDAY, May 25 – The incidence of bacterial meningitis dropped by 31 percent between 1998 and 2007, new government research shows. The drop was led by reductions in infections by two powerful germs – Neisseria meningitidis and Streptococcus pneumoniae – that are covered by available immunizations. With fewer infections among young children, the burden of the disease is now mainly borne by ...

Anti-Inflammatory Helps Treat Bacterial Meningitis: Study

Posted 29 Sep 2010 by

WEDNESDAY, Sept. 29 – Using the anti-inflammatory drug dexamethasone along with antibiotics increases the chance of surviving a bout with bacterial meningitis, Dutch researchers report. "Dexamethasone therapy reduces mortality from bacterial meningitis by one-third," said lead researcher Dr. Diederik van de Beek, a clinical neurologist from the Academic Medical Center at the University of ...

Ask a Question

Further Information

Related Condition Support Groups

Waterhouse-Friderichsen Syndrome, Bacterial Infection

Related Drug Support Groups

minocycline, dexamethasone, Decadron, sulfisoxazole, Minocin, Adrenocot, Adrenocot LA, Gantrisin, Dexone, view more... Decaject LA, Zema Pak, Decaject, Dexacorten, Dalalone DP, Dalalone, Baycadron, Ximino, Dexamethasone Intensol, Trumenba, Dexpak Taperpak, Medidex LA, Bexsero, Medidex, Dalalone LA, Dexasone, Primethasone, Truxazole, meningococcal group b vaccine, penicillin g sodium, penicillin g potassium, Dynacin, Myrac, Gantrisin Pediatric, Hexadrol, Dexone LA, Decadron-LA, Solurex LA, Dexacen-4, Solurex, De-Sone LA, Dexacort-LA, Dexasone LA, Pfizerpen